Negative impact of migraine on quality of life after 4 weeks of treatment in patients with major depressive disorder

Psychiatry and Clinical Neurosciences

Volumn 66, Issue 1, 2012, Pages 8-16

  Hung, Ching I ^a   Liu, Chia Yih ^a   Yang, Ching Hui ^b   Wang, Shuu Jiun ^c  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

depression; migraine; pain; prognosis; quality of life

Indexed keywords

VENLAFAXINE;

ADULT; AGED; ARTICLE; CONVALESCENCE; EMOTION; FEMALE; FUNCTIONAL ASSESSMENT; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL HEALTH; MIGRAINE; OUTPATIENT; QUALITY OF LIFE; SHORT FORM 36; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS; CYCLOHEXANOLS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIGRAINE DISORDERS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 84862965710     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2011.02286.x     Document Type: Article

References (39)

1. Dilsaver SC, Benazzi F, Oedegaard KJ, Fasmer OB, Akiskal HS,. Is a family history of bipolar disorder a risk factor for migraine among affectively ill patients? Psychopathology 2009; 42: 119-123.
2. Pompili M, Di Cosimo D, Innamorati M, Lester D, Tatarelli R, Martelletti P,. Psychiatric comorbidity in patients with chronic daily headache and migraine: A selective overview including personality traits and suicide risk. J. Headache Pain 2009; 10: 283-290.
3. Yalug I, Selekler M, Erdogan A, et al,. Correlations between alexithymia and pain severity, depression, and anxiety among patients with chronic and episodic migraine. Psychiatry Clin. Neurosci. 2010; 64: 231-238.
4. Breslau N, Lipton RB, Stewart WF, Schultz LR, Welch KM,. Comorbidity of migraine and depression: Investigating potential etiology and prognosis. Neurology 2003; 60: 1308-1312. (Pubitemid 36460987)
5. Hung CI, Liu CY, Wang SJ,. Precipitating or aggravating factors for headache in patients with major depressive disorder. J. Psychosom. Res. 2008; 64: 231-235.
6. Mongini F, Rota E, Deregibus A, et al,. Accompanying symptoms and psychiatric comorbidity in migraine and tension-type headache patients. J. Psychosom. Res. 2006; 61: 447-451. (Pubitemid 44441440)
7. Mercante JP, Bernik MA, Guendler VZ, Zukerman E, Kuczynski E, Peres MP,. Psychiatric comorbidities decrease quality of life in chronic migraine patients. Arq. Neuropsiquiatr 2007; 65: 880-884. (Pubitemid 47623460)
8. Canuet L, Ishii R, Fernandez-Concepcion O, Iwase M, Takeda M,. Severity of depressive symptoms as predictor of impairment of quality of life in chronic migraine: Comparison with episodic migraine. Psychiatry Clin. Neurosci. 2008; 62: 738-740.
9. Guidetti V, Galli F, Fabrizi P, et al,. Headache and psychiatric comorbidity: Clinical aspects and outcome in an 8-year follow-up study. Cephalalgia 1998; 18: 455-462. (Pubitemid 28459461)
10. Mongini F, Keller R, Deregibus A, Raviola F, Mongini T, Sancarlo M,. Personality traits, depression and migraine in women: A longitudinal study. Cephalalgia 2003; 23: 186-192. (Pubitemid 36461387)
11. Oedegaard KJ, Fasmer OB,. Is migraine in unipolar depressed patients a bipolar spectrum trait? J. Affect. Disord. 2005; 84: 233-242. (Pubitemid 40222505)
12. Hsu SC, Wang SJ, Liu CY, Juang YY, Yang CH, Hung CI,. The impact of anxiety and migraine on quality of sleep in patients with major depressive disorder. Compr. Psychiatry 2009; 50: 151-157.
13. Hung CI, Liu CY, Juang YY, Wang SJ,. The impact of migraine on patients with major depressive disorder. Headache 2006; 46: 469-477.
14. Hung CI, Liu CY, Chen JJ, Wang SJ,. Migraine predicts self-reported muscle tension in patients with major depressive disorder. Psychosomatics 2008; 49: 502-510.
15. Hung CI, Liu CY, Cheng TY, Wang SJ,. Migraine: A missing link between somatic symptoms and major depressive disorder. J. Affect. Disord. 2009; 117: 108-115.
16. Hung CI, Liu CY, Fuh JL, Juang YY, Wang SJ,. Comorbid migraine is associated with a negative impact on quality of life in patients with major depression. Cephalalgia 2006; 26: 26-32.
17. McIntyre RS, Konarski JZ, Wilkins K, Bouffard B, Soczynska JK, Kennedy SH,. The prevalence and impact of migraine headache in bipolar disorder: Results from the Canadian community health survey. Headache 2006; 46: 973-982. (Pubitemid 43794749)
18. Hung CI, Wang SJ, Yang CH, Liu CY,. The impacts of migraine, anxiety disorders, and chronic depression on quality of life in psychiatric outpatients with major depressive disorder. J. Psychosom. Res. 2008; 65: 135-142.
19. Demyttenaere K,. Quality of life in depression and anxiety: Does it matter? Int. J. Psychiatry Clin. Pract. 2006; 10 (Suppl. 1): 27-30.
20. Papakostas GI, Petersen T, Mahal Y, Mischoulon D, Nierenberg AA, Fava M,. Quality of life assessments in major depressive disorder: A review of the literature. Gen. Hosp. Psychiatry 2004; 26: 13-17. (Pubitemid 38142561)
21. Terwindt GM, Ferrari MD, Tijhuis M, Groenen SM, Picavet HS, Launer LJ,. The impact of migraine on quality of life in the general population: The GEM study. Neurology 2000; 55: 624-629.
22. Lipton RB, Hamelsky SW, Kolodner KB, Steiner TJ, Stewart WF,. Migraine, quality of life, and depression: A population-based case-control study. Neurology 2000; 55: 629-635.
23. Ozyalcin SN, Talu GK, Kiziltan E, Yucel B, Ertas M, Disci R,. The efficacy and safety of venlafaxine in the prophylaxis of migraine. Headache 2005; 45: 144-152. (Pubitemid 40315784)
24. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revision. American Psychiatric Association, Washington, DC, 2000.
25. First MB, Spitzer RL, Gibbon M, Williams JBW,. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P). Biometrics Research, New York State Psychiatric Institute, New York, 2002.
26. Hamilton M,. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 1967; 6: 278-296.
27. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd edition. Cephalalgia 2004; 24 (Suppl. 1): 1-160.
28. Ware JE, Sherbourne CD,. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 1992; 30: 473-483.
29. Tseng HM, Lu JF, Tsai YJ,. Assessment of health-related quality of life, II: Norming and validation of SF-36 Taiwan Version. Taiwan J. Public Health 2003; 22: 512-518.
30. Stahl SM, Grady MM, Moret C, Briley M,. SNRIs: Their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectr. 2005; 10: 732-747. (Pubitemid 41443048)
31. Swainston Harrison T, Keating GM,. Zolpidem: A review of its use in the management of insomnia. CNS Drugs 2005; 19: 65-89. (Pubitemid 40173974)
32. Quitkin FM, McGrath PJ, Stewart JW, et al,. Chronological milestones to guide drug change. When should clinicians switch antidepressants? Arch. Gen. Psychiatry 1996; 53: 785-792. (Pubitemid 26303619)
33. Trivedi MH, Morris DW, Grannemann BD, Mahadi S,. Symptom clusters as predictors of late response to antidepressant treatment. J. Clin. Psychiatry 2005; 66: 1064-1070. (Pubitemid 41191801)
34. Volpe FM,. An 8-week, open-label trial of Duloxetine for comorbid major depressive disorder and chronic headache. J. Clin. Psychiatry 2008; 69: 1449-1454.
35. Wang SJ, Fuh JL, Lu SR, Juang KD,. Quality of life differs among headache diagnoses: Analysis of SF-36 survey in 901 headache patients. Pain 2001; 89: 285-292.
36. Brandes JL,. Migraine and functional impairment. CNS Drugs 2009; 23: 1039-1045.
37. Karp JF, Scott J, Houck P, Reynolds CF 3rd, Kupfer DJ, Frank E,. Pain predicts longer time to remission during treatment of recurrent depression. J. Clin. Psychiatry 2005; 66: 591-597. (Pubitemid 40733701)
38. Greco T, Eckert G, Kroenke K,. The outcome of physical symptoms with treatment of depression. J. Gen. Intern. Med. 2004; 19: 813-818. (Pubitemid 39096352)
39. Mulder RT, Joyce PR, Frampton CM, Luty SE, Sullivan PF,. Six months of treatment for depression: Outcome and predictors of the course of illness. Am. J. Psychiatry 2006; 163: 95-100. (Pubitemid 43050109)